» Articles » PMID: 22729939

Loss of Wnt/β-catenin Signaling Causes Cell Fate Shift of Preosteoblasts from Osteoblasts to Adipocytes

Overview
Date 2012 Jun 26
PMID 22729939
Citations 130
Authors
Affiliations
Soon will be listed here.
Abstract

Wnt signaling is essential for osteogenesis and also functions as an adipogenic switch, but it is not known if interrupting wnt signaling via knockout of β-catenin from osteoblasts would cause bone marrow adiposity. Here, we determined whether postnatal deletion of β-catenin in preosteoblasts, through conditional cre expression driven by the osterix promoter, causes bone marrow adiposity. Postnatal disruption of β-catenin in the preosteoblasts led to extensive bone marrow adiposity and low bone mass in adult mice. In cultured bone marrow-derived cells isolated from the knockout mice, adipogenic differentiation was dramatically increased, whereas osteogenic differentiation was significantly decreased. As myoblasts, in the absence of wnt/β-catenin signaling, can be reprogrammed into the adipocyte lineage, we sought to determine whether the increased adipogenesis we observed partly resulted from a cell-fate shift of preosteoblasts that had to express osterix (lineage-committed early osteoblasts), from the osteoblastic to the adipocyte lineage. Using lineage tracing both in vivo and in vitro we showed that the loss of β-catenin from preosteoblasts caused a cell-fate shift of these cells from osteoblasts to adipocytes, a shift that may at least partly contribute to the bone marrow adiposity and low bone mass in the knockout mice. These novel findings indicate that wnt/β-catenin signaling exerts control over the fate of lineage-committed early osteoblasts, with respect to their differentiation into osteoblastic versus adipocytic populations in bone, and thus offers potential insight into the origin of bone marrow adiposity.

Citing Articles

Mogroside V enhances bone marrow mesenchymal stem cells osteogenesis under hyperglycemic conditions through upregulating miR-10b-5p and PI3K/Akt signaling.

Lan D, Li K, Ye Z, Luo Y, Li C, Li H J Orthop Surg Res. 2025; 20(1):278.

PMID: 40082984 PMC: 11907933. DOI: 10.1186/s13018-025-05684-5.


Amlexanox Enforces Osteogenic Differentiation and Bone Homeostasis Through Inhibiting Ubiquitin-Dependent Degradation of β-Catenin.

He Q, Liu Z, Xia X, Zeng J, Liu Y, Xun J Int J Biol Sci. 2024; 20(13):5254-5271.

PMID: 39430247 PMC: 11489180. DOI: 10.7150/ijbs.101507.


Skeletal stem and progenitor cells in bone physiology, ageing and disease.

Melis S, Trompet D, Chagin A, Maes C Nat Rev Endocrinol. 2024; 21(3):135-153.

PMID: 39379711 DOI: 10.1038/s41574-024-01039-y.


DDIT3 switches osteogenic potential of BMP9 to lipogenic by attenuating Wnt/β-catenin signaling via up-regulating DKK1 in mesenchymal stem cells.

Luo H, Ren W, Ye A, Liu L, Jiang Y, Ye F Aging (Albany NY). 2024; 16(18):12543-12558.

PMID: 39331002 PMC: 11466488. DOI: 10.18632/aging.206091.


The Myofibroblast Fate of Therapeutic Mesenchymal Stromal Cells: Regeneration, Repair, or Despair?.

Younesi F, Hinz B Int J Mol Sci. 2024; 25(16).

PMID: 39201399 PMC: 11354465. DOI: 10.3390/ijms25168712.


References
1.
Jeon M, Kim J, Kwon S, Kim S, Park K, Park S . Activation of peroxisome proliferator-activated receptor-gamma inhibits the Runx2-mediated transcription of osteocalcin in osteoblasts. J Biol Chem. 2003; 278(26):23270-7. DOI: 10.1074/jbc.M211610200. View

2.
Yang D, Guo J, Divieti P, Bringhurst F . Parathyroid hormone activates PKC-delta and regulates osteoblastic differentiation via a PLC-independent pathway. Bone. 2005; 38(4):485-96. DOI: 10.1016/j.bone.2005.10.009. View

3.
Rodda S, McMahon A . Distinct roles for Hedgehog and canonical Wnt signaling in specification, differentiation and maintenance of osteoblast progenitors. Development. 2006; 133(16):3231-44. DOI: 10.1242/dev.02480. View

4.
Krishnan V, Bryant H, MacDougald O . Regulation of bone mass by Wnt signaling. J Clin Invest. 2006; 116(5):1202-9. PMC: 1451219. DOI: 10.1172/JCI28551. View

5.
Yang D, Singh R, Divieti P, Guo J, Bouxsein M, Bringhurst F . Contributions of parathyroid hormone (PTH)/PTH-related peptide receptor signaling pathways to the anabolic effect of PTH on bone. Bone. 2007; 40(6):1453-61. PMC: 1976286. DOI: 10.1016/j.bone.2007.02.001. View